Cargando…
Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum
BACKGROUND: Several neurodegeneration (N) metrics using structural MRI are used for the purpose of Alzheimer's disease (AD)-related staging, including hippocampal volume, global atrophy, and an “AD signature” composite consisting of thickness or volumetric estimates derived from regions impacte...
Autores principales: | Allison, Samantha L., Koscik, Rebecca L., Cary, Robert P., Jonaitis, Erin M., Rowley, Howard A., Chin, Nathaniel A., Zetterberg, Henrik, Blennow, Kaj, Carlsson, Cynthia M., Asthana, Sanjay, Bendlin, Barbara B., Johnson, Sterling C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599872/ https://www.ncbi.nlm.nih.gov/pubmed/31252287 http://dx.doi.org/10.1016/j.nicl.2019.101895 |
Ejemplares similares
-
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019) -
Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status
por: Gallagher, Rigina L., et al.
Publicado: (2023) -
An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020) -
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease
por: Miners, James, et al.
Publicado: (2023) -
Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum
por: Moody, Jason F., et al.
Publicado: (2022)